Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenges Facing a Rural Opioid Epidemic: Treatment and Prevention of HIV and Hepatitis C
Asher J Schranz, Jessica L. Barrett, Christopher B. Hurt, et al.
Current HIV/AIDS Reports (2018) Vol. 15, Iss. 3, pp. 245-254
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers Within the Treatment System
Bertha K. Madras, N. Jia Ahmad, Jenny Wen, et al.
NAM Perspectives (2020)
Open Access | Times Cited: 189
The opioid crisis and HIV in the USA: deadly synergies
Sally Hodder, Judith Feinberg, Steffanie A. Strathdee, et al.
The Lancet (2021) Vol. 397, Iss. 10279, pp. 1139-1150
Closed Access | Times Cited: 88
Opioids and Infectious Diseases: A Converging Public Health Crisis
Tara A. Schwetz, Thomas Calder, Elana Rosenthal, et al.
The Journal of Infectious Diseases (2019) Vol. 220, Iss. 3, pp. 346-349
Open Access | Times Cited: 83
Advancing Digital Health Equity: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association
Brian R. Wood, J. D. Young, Rima Abdel-Massih, et al.
Clinical Infectious Diseases (2020) Vol. 72, Iss. 6, pp. 913-919
Open Access | Times Cited: 74
Community Perceptions of Comprehensive Harm Reduction Programs and Stigma Towards People Who Inject Drugs in Rural Virginia
Logan S. Baker, Walter H. Smith, Tauna Gulley, et al.
Journal of Community Health (2019) Vol. 45, Iss. 2, pp. 239-244
Closed Access | Times Cited: 57
Structural and community changes during COVID-19 and their effects on overdose precursors among rural people who use drugs: a mixed-methods analysis
Suzan M. Walters, Rebecca Bolinski, Ellen Almirol, et al.
Addiction Science & Clinical Practice (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 28
Evaluating non-medical prescription opioid demand using commodity purchase tasks: test-retest reliability and incremental validity
Justin C. Strickland, Joshua A. Lile, William W. Stoops
Psychopharmacology (2019) Vol. 236, Iss. 9, pp. 2641-2652
Open Access | Times Cited: 45
Rural risk environments, opioid-related overdose, and infectious diseases: A multidimensional, spatial perspective
Marynia Kolak, Yen‐Tyng Chen, Sam Joyce, et al.
International Journal of Drug Policy (2020) Vol. 85, pp. 102727-102727
Open Access | Times Cited: 41
Human Immunodeficiency Virus–Experienced Clinician Workforce Capacity: Urban–Rural Disparities in the Southern United States
Rose S. Bono, Bassam Dahman, Lindsay M. Sabik, et al.
Clinical Infectious Diseases (2020) Vol. 72, Iss. 9, pp. 1615-1622
Open Access | Times Cited: 40
Healthcare stigma and HIV risk among rural people who inject drugs
Hilary L. Surratt, Janet K. Otachi, Christopher J. McLouth, et al.
Drug and Alcohol Dependence (2021) Vol. 226, pp. 108878-108878
Open Access | Times Cited: 36
Sexual identity, sexual behavior, and drug use behaviors among people who use drugs in the rural U.S.
Wiley D. Jenkins, Lauren B. Beach, John A. Schneider, et al.
Journal of Substance Use and Addiction Treatment (2025), pp. 209629-209629
Closed Access
Outcomes of a pilot randomized clinical trial testing brief interventions to increase HIV pre-exposure prophylaxis uptake among rural people who inject drugs attending syringe services programs
Hilary L. Surratt, Sarah Brown, Abby L. Burton, et al.
Therapeutic Advances in Infectious Disease (2025) Vol. 12
Open Access
“I'm tired of seeing my friends die”: Barriers and facilitators to participating in clinical trials among rural people who use drugs in the United States
Kathryn E. Lancaster, Angela T. Estadt, Madison N. Enderle, et al.
The Journal of Rural Health (2025) Vol. 41, Iss. 1
Closed Access
How the rural risk environment underpins hepatitis C risk: Qualitative findings from rural southern Illinois, United States
Suzan M. Walters, David Frank, Marisa Felsher, et al.
International Journal of Drug Policy (2023) Vol. 112, pp. 103930-103930
Open Access | Times Cited: 12
Peer-assisted telemedicine hepatitis-C treatment for people who use drugs in rural communities: a mixed methods study
Kim Hoffman, Gillian Leichtling, Sarah Shin, et al.
Addiction Science & Clinical Practice (2025) Vol. 20, Iss. 1
Open Access
Retention in buprenorphine treatment is associated with improved HCV care outcomes
Brianna L. Norton, A. Beitin, Matthew C. Glenn, et al.
Journal of Substance Abuse Treatment (2017) Vol. 75, pp. 38-42
Open Access | Times Cited: 35
COVID‐19 and Rural Harm Reduction Challenges in the US Southern Mountains
Bayla Ostrach, Lesly‐Marie Buer, Sam Armbruster, et al.
The Journal of Rural Health (2020) Vol. 37, Iss. 1, pp. 252-255
Open Access | Times Cited: 25
The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the Netherlands: findings from an emulated target trial
Daniela K van Santen, Anders Boyd, Amy Matser, et al.
Addiction (2021) Vol. 116, Iss. 11, pp. 3115-3126
Open Access | Times Cited: 19
Injections and infections: understanding syringe service program utilization in a rural state
Kinna Thakarar, Nitysari Sankar, Kimberly Murray, et al.
Harm Reduction Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 18
Pre-Exposure Prophylaxis Barriers, Facilitators and Unmet Need Among Rural People Who Inject Drugs: A Qualitative Examination of Syringe Service Program Client Perspectives
Hilary L. Surratt, Hannah J. Yeager, Akosua Adu, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 13
Rural communities face more than an opioid crisis: Reimagining funding assistance to address polysubstance use, associated health problems, and limited rural service capacity
Carolyn Carpenedo Mun, Heather Schuler, Robin Baker, et al.
The Journal of Rural Health (2023) Vol. 39, Iss. 4, pp. 795-803
Open Access | Times Cited: 7
Use of Population-Based Surveys for Estimating the Population Size of Persons Who Inject Drugs in the United States
Heather Bradley, Elizabeth M. Rosenthal, Meredith A. Barranco, et al.
The Journal of Infectious Diseases (2020) Vol. 222, Iss. Supplement_5, pp. S218-S229
Open Access | Times Cited: 20
System-Level Factors Shaping the Implementation of “Hub and Spoke” Systems to Expand MOUD in Rural Areas
Claire Snell‐Rood, Cathleen E. Willging, David Showalter, et al.
Substance Abuse (2020) Vol. 42, Iss. 4, pp. 716-725
Open Access | Times Cited: 20
The Relationship Between Polysubstance Injection Drug Use, HIV Risk Behaviors, and Interest in Pre-Exposure Prophylaxis (PrEP) Among People Who Inject Drugs in Rural West Virginia
Kristin E. Schneider, Rebecca Hamilton White, Rashelle J. Musci, et al.
Journal of Studies on Alcohol and Drugs (2020) Vol. 81, Iss. 6, pp. 740-749
Open Access | Times Cited: 20
Rural–Urban Differences in Hospitalizations for Opioid Use–Associated Infective Endocarditis in the United States, 2003–2016
E Katherine Nenninger, Jenny L. Carwile, Katherine A. Ahrens, et al.
Open Forum Infectious Diseases (2020) Vol. 7, Iss. 2
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top